- Home
- RPRX vs J Comparison
RPRX vs J Comparison
Compare RPRX & J Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- J
- Stock Information
- Founded
- RPRX 1996
- J 1947
- Country
- RPRX United States
- J United States
- Employees
- RPRX N/A
- J N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- J Military/Government/Technical
- Sector
- RPRX Health Care
- J Industrials
- Exchange
- RPRX Nasdaq
- J Nasdaq
- Market Cap
- RPRX 16.2B
- J 17.5B
- IPO Year
- RPRX 2020
- J N/A
- Fundamental
- Price
- RPRX $39.23
- J $154.33
- Analyst Decision
- RPRX Strong Buy
- J Buy
- Analyst Count
- RPRX 3
- J 9
- Target Price
- RPRX $46.00
- J $163.25
- AVG Volume (30 Days)
- RPRX 3.9M
- J 1.2M
- Earning Date
- RPRX 11-05-2025
- J 11-20-2025
- Dividend Yield
- RPRX 2.25%
- J 0.83%
- EPS Growth
- RPRX N/A
- J N/A
- EPS
- RPRX 1.75
- J 4.00
- Revenue
- RPRX $2,349,844,000.00
- J $11,835,289,000.00
- Revenue This Year
- RPRX $36.16
- J N/A
- Revenue Next Year
- RPRX $2.04
- J $6.65
- P/E Ratio
- RPRX $22.36
- J $39.20
- Revenue Growth
- RPRX 3.70
- J 61.50
- 52 Week Low
- RPRX $24.05
- J $105.18
- 52 Week High
- RPRX $41.24
- J $168.44
- Technical
- Relative Strength Index (RSI)
- RPRX 59.26
- J 48.35
- Support Level
- RPRX $38.39
- J $151.86
- Resistance Level
- RPRX $40.01
- J $157.00
- Average True Range (ATR)
- RPRX 1.26
- J 3.13
- MACD
- RPRX 0.12
- J -0.62
- Stochastic Oscillator
- RPRX 63.19
- J 42.67
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About J Jacobs Solutions Inc.
Jacobs Solutions is a global provider of engineering, design, procurement, construction, and maintenance services as well as cyber engineering and security solutions. The firm serves industrial, commercial, and government clients in a wide variety of sectors, including water, transportation, healthcare, technology, and chemicals. Jacobs Solutions employs approximately 60,000 workers. The company generated $11.5 billion in revenue in fiscal 2024.